logo

For the Inventor, By the Inventor

Sugar Land, TX, United States of America

Gang Liu

This inventor holds 13 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: The University of Texas System. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gang Liu. Retrieved from https://idiyas.com/inventor/gang-liu-2o4zhp3a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 92(Granted Patents)


Location History:

  • Houston, TX (US) (2015)
  • Sugar Land, TX (US) (2017 - 2024)

Company Filing History:

goldMedal13 out of 5,644 
 
The University of Texas System
 patents

Years Active: 2015-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12252480 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide (2025-03-18),
2. 11958849 - GLS1 inhibitors for treating disease (2024-04-16),
3. 11603365 - Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide (2023-03-14),
4. 11370786 - GLS1 inhibitors for treating disease (2022-06-28),
5. 10899769 - Imidazopiperazinone inhibitors of transcription activating proteins (2021-01-26),
6. 10899740 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide (2021-01-26),
7. 10766892 - GLS1 inhibitors for treating disease (2020-09-08),
8. 10428057 - Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease (2019-10-01),
9. 10344025 - GLS1 inhibitors for treating disease (2019-07-09),
10. 10150753 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide (2018-12-11),
11. 10093664 - Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease (2018-10-09),
12. 9809588 - GLS1 inhibitors for treating disease (2017-11-07),
13. 9115120 - Heterocyclic modulators of HIF activity for treatment of disease (2015-08-25),

Title: The Inventive Journey of Gang Liu

Introduction: Gang Liu, a talented inventor hailing from Sugar Land, TX, has made significant contributions to the world of innovation with his groundbreaking ideas and creations.

Latest Patents: Gang Liu's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution for urban environments.

Career Highlights: With a background in electrical engineering, Gang Liu has spent over two decades honing his skills in developing cutting-edge technologies. He has worked for leading tech companies, where he played a key role in the development of advanced electronic systems.

Collaborations: Throughout his career, Gang Liu has collaborated with top researchers and engineers in the field, fostering a culture of innovation and creativity. His collaborative projects have resulted in patents that have transformed industries.

Conclusion: Gang Liu's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…